8-K – 2026-03-02 – isrg-20260301.htm

isrg-20260301 0001035267 FALSE 0001035267 2026-03-01 2026-03-01

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549  

FORM 8-K  

CURRENT REPORT
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 1, 2026

INTUITIVE SURGICAL, INC.
(Exact name of registrant as specified in its charter)

Delaware   000-30713   77-0416458
(State or Other Jurisdiction
of Incorporation)
  (Commission
File Number)   (I.R.S. Employer
Identification No.)

1020 Kifer Road
Sunnyvale , California   94086
(Address of Principal Executive Offices) (zip code)
Registrant’s telephone number, including area code: ( 408 )  523-2100

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.001 per share   ISRG   The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨   
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨   

Item 8.01.
Other Events

On March 2, 2026, Intuitive Surgical, Inc. (the “Company”) issued a press release announcing the completion of its acquisition on March 1, 2026, of the da Vinci and Ion distribution business operated by ab medica, Abex, Excelencia Robótica, and their affiliates. A copy of the Company’s press release is included as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference; provided, however, that information on or connected to our website or the website of any third-party hyperlinked from or referenced in the Company’s press release included as Exhibit 99.1 to this Current Report on Form 8-K is expressly not incorporated by reference into or intended to be filed as a part of this Current Report on Form 8-K.

Item 9.01. Financial Statements and Exhibits.

d) Exhibits.
Exhibit No. Description

99.1 Press release issued by Intuitive Surgical, Inc., dated March 2, 2026

104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  INTUITIVE SURGICAL, INC.

Date: March 2, 2026   By: /s/ JAMIE E. SAMATH
       Name:  Jamie E. Samath

  Title: Executive Vice President, Chief Financial Officer